Keywords: Novo Nordisk, Victoza, Diabetes type 2, BMI, Body mass index

Novo Nordisk’s Victoza shows diabetes potential beyond glucose control

Article | 09 November 2010

Print This

Recent research results demonstrate that a new treatment approach to diabetes, GLP-1 analogues, not only helps to lower blood glucose ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in